member
research
publication
photo
access
link
contact

 
 

20212020201920182017201620152014201320122011201020092008200720062005以前

  2018年度  
受賞歴   

原著論文
   鎌田 春彦

Tomita K, Sakurai F, Iizuka S, Hemmi M, Wakabayashi K, Machitani M, Tachibana M, Katayama K, Kamada H, Mizuguchi H. Antibodies against adenovirus fiber and penton base proteins inhibit adenovirus vector-mediated transduction in the liver following systemic administration. Sci Rep. 8(1):12315. 2018

Yokoi H, Kasahara Y, Obika S, Doi T, Kamada H. Development of a detection method for antisense oligonucleotides in mouse kidneys by MALDI imaging mass spectrometry. Rapid Commun Mass Spectrom. 32(23):1984-1990. (2018)


永田 諭志
Bera TK, Abe Y, Ise T, Oberle A, Gallardo D, Liu XF, Nagata S, Binder M, Pastan I.Recombinant immunotoxins targeting B-cell maturation antigen are cytotoxic to myeloma cell lines and myeloma cells from patients. Leukemia. 32(2):569, 2018

Khan S, Zafar N, Khan SS, Setua S, Behrman SW, Stiles ZE, Yallapu MM, Sahay P, Ghimire H, Ise T, Nagata S, Wang L, Wan JY, Pradhan P, Jaggi M, Chauhan SC. Clinical significance of MUC13 in pancreatic ductal adenocarcinoma. HPB (Oxford). pii: S1365-182X(17)31184-X., 2018

Evans RL, Pottala JV, Nagata S, Egland KA: Longitudinal autoantibody responses against tumor- associated antigens decrease in breast cancer patients according to treatment modality. BMC Cancer, 18:119, 2018

Shancer Z, Williams M, Igelman A, Nagata S, Ise T, Pastan I, Bera TK. Preclinical development of anti-BCMA immunotoxins targeting multiple myeloma. Antib Ther. 1(1):19-25. 2018

(その他)
永田諭志,伊勢知子,鎌田春彦, 標的に抗体が結合できる部位はいくつあるか? 次世代抗体医薬の衝撃, 実験医学, 36(11) 1867-1874 (2018)